Ostora FDA Approval Status
FDA Approved: No
Brand name: Ostora
Generic name: calcitonin
Company: Tarsa Therapeutics
Treatment for: Osteoporosis
Ostora (calcitonin) is an oral recombinant salmon calcitonin formulation in development for the treatment of postmenopausal osteoporosis.
Development timeline for Ostora
| Date | Article |
|---|---|
| Dec 13, 2011 | Tarsa Therapeutics Targets 2012 NDA Submission for its Ostora Oral Calcitonin |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
